keyword
https://read.qxmd.com/read/38627909/from-taboo-to-treatment-the-emergence-of-psychedelics-in-the-management-of-pain-and-opioid-use-disorder
#1
REVIEW
Jeremy Weleff, Julio C Nunes, Gabriel P A Costa, Mehmet Sofuoglu, R Ross MacLean, Joao P De Aquino
The rise of psychedelics in contemporary medicine has sparked interest in their potential therapeutic applications. While traditionally associated with countercultural movements and recreational use, recent research has shed light on the potential benefits of psychedelics in various mental health conditions. In this review, we explore the possible role of psychedelics in the management of chronic pain and opioid use disorder (OUD), 2 critical areas in need of innovative treatment options. Pain control remains a significant clinical challenge, particularly for individuals with OUD and those who receive long-term opioid therapy who develop marked tolerance to opioid-induced analgesia...
April 16, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38626303/opioid-use-disorder-in-pediatric-populations-considerations-for-perioperative-pain-management-and-precision-opioid-analgesia
#2
REVIEW
Yun Han Chen, Anastasios Xenitidis, Paul Hoffman, Leslie Matthews, Swathi G Padmanabhan, Lakshmi Aravindan, Ruth Ressler, Inesh Sivam, Sahana Sivam, Chase F Gillispie, Senthilkumar Sadhasivam
INTRODUCTION: Opioids are commonly used for perioperative analgesia, yet children still suffer high rates of severe post-surgical pain and opioid-related adverse effects. Persistent and severe acute surgical pain greatly increases the child's chances of chronic surgical pain, long-term opioid use, and opioid use disorder. AREAS COVERED: Enhanced recovery after surgery (ERAS) protocols, are often inadequate in treating a child's severe surgical pain. Research suggests that 'older' and longer-acting opioids such as methadone are providing better methods to treat acute post-surgical pain...
April 16, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38612817/in-vitro-and-in-vivo-pharmacological-profiles-of-lenart01-a-dermorphin-ranatensin-hybrid-peptide
#3
JOURNAL ARTICLE
Nadine Hochrainer, Pawel Serafin, Sara D'Ingiullo, Adriano Mollica, Sebastian Granica, Marek Brytan, Patrycja Kleczkowska, Mariana Spetea
Diverse chemical and pharmacological strategies are currently being explored to minimize the unwanted side effects of currently used opioid analgesics while achieving effective pain relief. The use of multitarget ligands with activity at more than one receptor represents a promising therapeutic approach. We recently reported a bifunctional peptide-based hybrid LENART01 combining dermorphin and ranatensin pharmacophores, which displays activity to the mu-opioid receptor (MOR) and dopamine D2 receptor (D2R) in rat brains and spinal cords...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612660/advancements-in-regenerative-hydrogels-in-skin-wound-treatment-a-comprehensive-review
#4
REVIEW
Gabriel Olteanu, Sorinel Marius Neacșu, Florin Alexandru Joița, Adina Magdalena Musuc, Elena Carmen Lupu, Corina-Bianca Ioniță-Mîndrican, Dumitru Lupuliasa, Magdalena Mititelu
This state-of-the-art review explores the emerging field of regenerative hydrogels and their profound impact on the treatment of skin wounds. Regenerative hydrogels, composed mainly of water-absorbing polymers, have garnered attention in wound healing, particularly for skin wounds. Their unique properties make them well suited for tissue regeneration. Notable benefits include excellent water retention, creating a crucially moist wound environment for optimal healing, and facilitating cell migration, and proliferation...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611770/development-and-validation-of-a-high-performance-liquid-chromatography-method-to-quantify-marker-compounds-in-lysimachia-vulgaris-var-davurica-and-its-effects-in-diarrhea-predominant-irritable-bowel-syndrome
#5
JOURNAL ARTICLE
Hye-Youn Kim, Cho-Een Kim, Dool-Ri Oh, Yonguk Kim, Chul-Yung Choi, Jaeyong Kim
Irritable bowel syndrome (IBS), a common gastrointestinal disorder worldwide, is characterized by chronic abdominal pain, bloating, and disordered defecation. IBS is associated with several factors, including visceral hypersensitivity, gut motility, and gut-brain interaction disorders. Because currently available pharmacological treatments cannot adequately improve symptoms and may cause adverse effects, the use of herbal therapies for managing IBS is increasing. Lysimachia vulgaris var. davurica (LV) is a medicinal plant used in traditional medicine to treat diarrhea...
March 27, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38592310/the-role-of-anxiety-and-depression-in-shaping-the-sleep-pain-connection-in-patients-with-nonspecific-chronic-spinal-pain-and-comorbid-insomnia-a-cross-sectional-analysis
#6
JOURNAL ARTICLE
Zosia Goossens, Thomas Bilterys, Eveline Van Looveren, Anneleen Malfliet, Mira Meeus, Lieven Danneels, Kelly Ickmans, Barbara Cagnie, Aurore Roland, Maarten Moens, Jo Nijs, Liesbet De Baets, Olivier Mairesse
(1) Background : This exploratory study aims to explore the relationship between nonspecific chronic spinal pain (nCSP) and insomnia symptoms, by examining the interconnections, strengths, and directional dependence of the symptoms. In addition, we aim to identify the key symptoms of the nCSP-insomnia relationship and shed light on the bidirectional nature of this relationship. (2) Methods : This study is a secondary analysis of the baseline data (cross-sectional) from a randomized controlled trial, which examined the added value of Cognitive Behavioral Therapy for Insomnia (CBT-I) combined with cognition-targeted exercise therapy, conducted in collaboration with the Universiteit Gent and Vrije Universiteit Brussel (Belgium)...
March 2, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38590725/computational-inhibition-of-s100a8-calgranulin-a-as-a-potential-non-invasive-biomarker-for-rheumatoid-arthritis
#7
JOURNAL ARTICLE
Khushboo Choudhury, Abhipsha Khadanga, Ram Singh Purty
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic joint pain and inflammation, loss of mobility, which affects the quality of life. The etiology of RA is unknown, and there is no isolated cause for the development of this illness. Synovial inflammation, autoantibody generation and bone degradation leading to deformity are classic characteristics of RA. The search for a non-invasive biomarker is crucial for helping patients receive standard therapies leading to faster treatments, as diagnosis depends on invasive biopsies...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38589241/chronic-interstitial-ectopic-pregnancy-presenting-with-a-negative-urine-pregnancy-test
#8
JOURNAL ARTICLE
Apiwat Jongjakapun, Lingling Salang, Apiwat Aueaungkul, Pilaiwan Kleebkaow
The ampulla portion of the fallopian tube is the most common site of ectopic pregnancy (70%), with approximately 2% of pregnancies implanted in the interstitial portion. In general, an interstitial ectopic pregnancy (IEP) is difficult to diagnose and is associated with a high rate of complications-most patients with an IEP present with severe abdominal pain and haemorrhagic shock due to an ectopic rupture. Chronic tubal pregnancy (CTP) is an uncommon condition with an incidence of 20%. The CTP has a longer clinical course and a negative or low level of serum beta-human chorionic gonadotropin due to perished chorionic villi...
April 8, 2024: BMJ Case Reports
https://read.qxmd.com/read/38586085/exploration-of-the-molecular-mechanism-guiding-xinfeng-capsule-regulatory-mechanism-for-rheumatoid-arthritis-inflammation
#9
JOURNAL ARTICLE
Ziheng Zhu, Lei Wan
OBJECTIVES: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joint synovium. The traditional Chinese medicine Xinfeng capsule (XFC) has a remarkable alleviating effect on inflammatory symptoms, such as joint pain and swelling, in patients with RA. However, the underlying mechanism of action remains to be elucidated. This study intended to conduct network pharmacology, animal experiments, data mining, and molecular docking to explore the molecular mechanism through which XFC can improve the inflammatory symptoms of RA...
2024: American Journal of Translational Research
https://read.qxmd.com/read/38576366/opioid-induced-constipation-old-and-new-concepts-in-diagnosis-and-treatment
#10
REVIEW
Francesco Squeo, Francesca Celiberto, Enzo Ierardi, Francesco Russo, Giuseppe Riezzo, Benedetta D'Attoma, Alfredo Di Leo, Giuseppe Losurdo
Daily use of opioid analgesics has significantly increased in recent years due to an increasing prevalence of conditions associated with chronic pain. Opioid-induced constipation (OIC) is one of the most common, under-recognized, and under-treated side effects of opioid analgesics. OIC significantly reduces the quality of life by causing psychological distress, lowering work productivity, and increasing access to healthcare facilities. The economic and social burden of OIC led to the development of precise strategies for daily clinical practice...
April 30, 2024: Journal of Neurogastroenterology and Motility
https://read.qxmd.com/read/38574622/antinociceptive-effect-of-lmh-2-a-new-sigma-1-receptor-antagonist-analog-of-haloperidol-on-the-neuropathic-pain-of-diabetic-mice
#11
JOURNAL ARTICLE
Rosa Ventura-Martínez, Guadalupe Esther Ángeles-López, Diana González-Ugalde, Tania Domínguez-Páez, Gabriel Navarrete-Vázquez, Ruth Jaimez, Myrna Déciga-Campos
This study evaluates the antiallodynic and antihyperalgesic effects of LMH-2, a new haloperidol (HAL) analog that acts as sigma-1 receptor (σ1 R) antagonist, in diabetic mice using a model of neuropathic pain induced by chronic hyperglycemia. Additionally, we compared its effects with those of HAL. Hyperglycemia was induced in mice by nicotinamide-streptozotocin administration (NA-STZ, 50-130 mg/kg). Four weeks later, mechanical allodynia was assessed using the up-down method, and hyperalgesia was evoked with formalin 0...
April 3, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38572785/stigmasterol-alleviates-neuropathic-pain-by-reducing-schwann-cell-macrophage-cascade-in-drg-by-modulating-il-34-csf1r
#12
JOURNAL ARTICLE
Waimei Si, Zhenni Chen, Jing Bei, Shiquan Chang, Yachun Zheng, Li Gao, Guoping Zhao, Xin Li, Di Zhang
AIMS: This study aimed to investigate the potential therapeutic applications of stigmasterol for treating neuropathic pain. METHODS: Related mechanisms were investigated by DRG single-cell sequencing analysis and the use of specific inhibitors in cellular experiments. In animal experiments, 32 male Sprague-Dawley rats were randomly divided into the sham operation group, CCI group, ibuprofen group, and stigmasterol group. We performed behavioral tests, ELISA, H&E staining and immunohistochemistry, and western blotting...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38563040/frontline-perspectives-on-buprenorphine-for-the-management-of-chronic-pain
#13
REVIEW
Jeremy Adler, Theresa Mallick-Searle, Mark Garofoli, Amanda Zimmerman
Due to the prevalence of chronic pain and high-impact chronic pain in the US, a significant percentage of the population is prescribed opioids for pain management. However, opioid use disorder is associated with reduced quality of life, along with fatal opioid overdoses, and is a significant burden on the US economy. Considering the clinical needs of patients with intractable chronic pain and the potential harms associated with prescribed and illicit opioids in our communities, having a deep understanding of current treatment options, supporting evidence, and clinical practice guidelines is essential for optimizing treatment selections...
2024: Journal of Multidisciplinary Healthcare
https://read.qxmd.com/read/38555180/making-decisions-about-amputation-for-chronic-limb-threatening-ischaemia
#14
JOURNAL ARTICLE
Susan Monaro, Sandra West, Janice Gullick
INTRODUCTION: Chronic limb threatening ischaemia causes pain, loss of function and complex wounds, necessitating urgent interventions. While growing options for minimally invasive revascularisation make operating on frail and older persons safer, the challenge is knowing when to stop this option and offer amputation. Decisions about amputation are difficult for the person, or for the family who act as substitute decision-makers. Timely treatment decisions are important to optimise clinical outcomes but do not always align with outcomes that are acceptable to patients...
March 2024: Journal of Vascular Nursing: Official Publication of the Society for Peripheral Vascular Nursing
https://read.qxmd.com/read/38550263/study-protocol-for-a-three-arm-randomized-controlled-trial-investigating-the-effectiveness-cost-utility-and-physiological-effects-of-a-fully-self-guided-digital-acceptance-and-commitment-therapy-for-spanish-patients-with-fibromyalgia
#15
JOURNAL ARTICLE
Ana Gallego, Mayte Serrat, Estíbaliz Royuela-Colomer, Juan P Sanabria-Mazo, Xavier Borràs, Montserrat Esteve, Mar Grasa, Araceli Rosa, Antoni Rozadilla-Sacanell, Miriam Almirall, Francesco D'Amico, Yifei Dai, Michael J Rosenbluth, Lance M McCracken, Jaime Navarrete, Albert Feliu-Soler, Juan V Luciano
OBJECTIVE: Fibromyalgia (FM) is a prevalent pain syndrome with significant healthcare and societal costs. The aim of the SMART-FM-SP study is to determine the effectiveness, cost-utility, and physiological effects in patients with FM of a digital intervention (STANZA®) currently marketed in the United States, which delivers smartphone-based, fully self-guided Acceptance and Commitment Therapy (Digital ACT) for treating FM-related symptoms. METHODS: A single-site, parallel-group, superiority, randomized controlled trial (RCT) will be conducted, including a total of 360 adults diagnosed with FM...
2024: Digital Health
https://read.qxmd.com/read/38545497/-i-felt-part-of-the-solution-a-qualitative-study-about-the-interface-between-lived-experience-advocates-professionals-and-organisations-in-the-field-of-persistent-pain
#16
JOURNAL ARTICLE
Cameron Hartley, Chris Penlington
OBJECTIVES: To elicit perspectives of people with persistent pain about their experiences working with pain management professionals and services as patient advocates and to consider implications for current models of involving patients in service development and research. DESIGN: reflexive thematic analysis from a critical realist perspective. METHODS: Online interviews were conducted individually with 10 participants who had acted as patient advocates in the field of persistent pain...
April 2024: British Journal of Pain
https://read.qxmd.com/read/38540290/beyond-pain-relief-unveiling-the-multifaceted-impact-of-anti-cgrp-r-mabs-on-comorbid-symptoms-in-resistant-migraine-patients
#17
JOURNAL ARTICLE
Alessandra Della Vecchia, Ciro De Luca, Lucrezia Becattini, Letizia Curto, Elena Ferrari, Gabriele Siciliano, Sara Gori, Filippo Baldacci
The study aimed to evaluate the effects of monoclonal antibodies (mAbs) acting on the calcitonin gene-related peptide (CGRP) or its receptor (anti-CGRP/R mAbs) on migraine comorbidities of depression, anxiety, and fatigue in patients resistant to traditional therapies. The issue addressed in this study is pivotal to unveiling the role of this neurotransmitter beyond pain processing. We conducted an open-label prospective study assessing comorbidities in patients with high frequency (HFEM) and chronic migraine (CM), medication overuse headache (MOH), and resistance to traditional prophylaxis...
March 18, 2024: Biomedicines
https://read.qxmd.com/read/38539187/benchmark-findings-from-a-veteran-electronic-patient-reported-outcomes-evaluation-from-a-chronic-pain-management-telehealth-program
#18
JOURNAL ARTICLE
Jolie N Haun, Christopher A Fowler, Bridget M Smith, Lishan Cao, Kevin T Stroupe, William A Lapcevic, Michael S Saenger, Rachel C Benzinger, Dustin D French
BACKGROUND: Chronic pain is a leading cause of disability and negatively impacts biological/physical, psychological, and social aspects of life resulting in significant pain interference or disability. This project was part of a longitudinal mixed-methods implementation evaluation of the TelePain-Empower Veterans Program (EVP), a non-pharmacological chronic pain intervention. The purpose of this quality management project was to examine electronic patient-reported outcome measures (ePROs) including primary pain-related (intensity, interference, catastrophizing, kinesiophobia) and secondary outcomes (physical, psychological, acceptance, social) to determine TelePain-EVP effectiveness...
March 28, 2024: BMC Health Services Research
https://read.qxmd.com/read/38525728/a-systematic-review-of-naldemedine-and-naloxegol-for-the-treatment-of-opioid-induced-constipation-in-cancer-patients
#19
REVIEW
Ursula K Braun, Leanne K Jackson, Mary A Garcia, Syed N Imam
BACKGROUND: Opioid-induced constipation (OIC) is a pervasive and distressing side effect of chronic opioid therapy in patients with cancer pain, significantly impacting their quality of life. Peripherally acting μ-opioid receptor antagonists (PAMORAS) were developed for treatment-resistant OIC but most studies were conducted with non-cancer patients. OBJECTIVE: to discuss two oral formulations of PAMORAs, naldemedine and naloxegol, and to review available evidence of the effectiveness of these drugs for OIC in cancer patients...
March 6, 2024: Pharmacy (Basel, Switzerland)
https://read.qxmd.com/read/38523607/eptinezumab-for-the-preventive-treatment-of-episodic-and-chronic-migraine-a-narrative-review
#20
REVIEW
Pablo Irimia, Sonia Santos-Lasaosa, Patricia Pozo-Rosich, Rogelio Leira, Julio Pascual, José Miguel Láinez
Eptinezumab, a monoclonal antibody that targets calcitonin gene-related peptide (CGRP), was recently approved in Europe for the prophylactic treatment of migraine in adults who have at least four migraine days a month. Eptinezumab is administered by intravenous infusion every 12 weeks. During recent months, a considerable amount of evidence from eptinezumab trials has been published. The aim of this review is to describe the existing evidence on the tolerability, safety and efficacy of eptinezumab in patients with migraine...
2024: Frontiers in Neurology
keyword
keyword
62115
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.